- Home
- NTIC vs INKT Comparison
NTIC vs INKT Comparison
Compare NTIC & INKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTIC
- INKT
- Stock Information
- Founded
- NTIC 1970
- INKT 2017
- Country
- NTIC United States
- INKT United States
- Employees
- NTIC N/A
- INKT N/A
- Industry
- NTIC Industrial Specialties
- INKT Medicinal Chemicals and Botanical Products
- Sector
- NTIC Industrials
- INKT Health Care
- Exchange
- NTIC Nasdaq
- INKT Nasdaq
- Market Cap
- NTIC 73.7M
- INKT 69.2M
- IPO Year
- NTIC N/A
- INKT 2021
- Fundamental
- Price
- NTIC $7.76
- INKT $14.40
- Analyst Decision
- NTIC
- INKT Buy
- Analyst Count
- NTIC 0
- INKT 3
- Target Price
- NTIC N/A
- INKT $37.50
- AVG Volume (30 Days)
- NTIC 14.5K
- INKT 55.3K
- Earning Date
- NTIC 07-10-2025
- INKT 08-14-2025
- Dividend Yield
- NTIC 0.51%
- INKT N/A
- EPS Growth
- NTIC N/A
- INKT N/A
- EPS
- NTIC 0.31
- INKT N/A
- Revenue
- NTIC $85,268,129.00
- INKT N/A
- Revenue This Year
- NTIC $1.09
- INKT N/A
- Revenue Next Year
- NTIC $5.69
- INKT N/A
- P/E Ratio
- NTIC $25.20
- INKT N/A
- Revenue Growth
- NTIC 3.46
- INKT N/A
- 52 Week Low
- NTIC $6.75
- INKT $4.56
- 52 Week High
- NTIC $15.09
- INKT $76.00
- Technical
- Relative Strength Index (RSI)
- NTIC 52.74
- INKT 47.71
- Support Level
- NTIC $7.75
- INKT $13.11
- Resistance Level
- NTIC $8.09
- INKT $16.20
- Average True Range (ATR)
- NTIC 0.19
- INKT 1.21
- MACD
- NTIC 0.06
- INKT 0.05
- Stochastic Oscillator
- NTIC 60.71
- INKT 40.40
About NTIC Northern Technologies International Corporation
Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.
About INKT MiNK Therapeutics Inc.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.